CRH Medical Corporation

Available to platforms
R StocksTrader

CRH Medical Corporation (CRHM) on the NYSE Exchange

Company overview

CRH Medical Corporation is a publicly listed company from USA with shares traded on NYSE under the ticker CRHM. This page provides a live view of market pricing and an interactive chart to follow short and long-term moves without manual refresh. The latest streaming quotes for CRHM are bid 19.95 USD and ask 20.05 USD.

Use the chart to review recent momentum, identify key price areas, and track how CRH Medical Corporation is performing relative to your portfolio in 2025. If you are researching the instrument for trading or investing, add CRHM to your watchlist in R StocksTrader and compare it with other US and European shares, indices, and metals.

Key facts

  • Exchange: NYSE
  • Company: CRH Medical Corporation
  • Ticker: CRHM
  • Country: USA
  • Bid19.95 USD
  • Ask20.05 USD
  • Quotes: real-time, auto-updated

Risk

Risk Warning: Past performance of CRHM does not predict future returns.

FAQ

Open a trading account at RoboForex, decide on the number of assets to buy, and then place an order for CRH Medical Corporation (CRHM) in R StocksTrader. Create and verify your profile, fund the account, search for CRHM, and choose the instrument type available to you. Add CRHM to your Watchlist to track moves and manage open positions throughout 2025.

CRHM trades on NYSE and is issued by CRH Medical Corporation. This page provides a live chart and continuously updated price data for the 2025 year so that you can follow intraday swings and longer trends. Before starting trading and placing orders, review trading hours, typical spreads, and fees in the terminal to make sure conditions for CRHM match your plan.

Quotes update automatically in real time. Current levels for CRHM are bid 19.95 USD and ask 20.05 USD. The spread is the difference between ask and bid and affects your effective entry and exit. Track CRHM in R StocksTrader and adjust your approach as market conditions change in 2025.